Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

31.94 -0.17 (-0.53%)
Streaming Delayed Price Updated: 11:41 AM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Collegium Pharmaceutical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Announces $50 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
 
Via Benzinga
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Participate in Jefferies Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Earnings Outlook For Collegium Pharmaceutical
 
Via Benzinga
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
 
Via Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Collegium Reports First Quarter 2023 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
Highlights 2022 environmental, social and governance achievements 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Provides 2023 Financial Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expiry 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Reports Third Quarter 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
  
Via Benzinga
7 Micro-Cap Stocks to Take a Chance on Now
Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors. 
Via InvestorPlace
A Preview Of Collegium Pharmaceutical's Earnings
Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock? 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.